Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Echo IQECHQF 13 EV-to-EBIT is -65.28 as of Jul. 23, 2026. GuruFocus rates ECHQF with a GF Score™ of 13/100 and a GF Value™ of $0.02 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 468 Healthcare Providers & Services companies, Echo IQ ranks worse than 213675% on this metric.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Echo IQ's Enterprise Value is $699.73 Mil.
Echo IQ's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $-10.72 Mil. Therefore, Echo IQ's EV-to-EBIT for today is -65.28.
The historical rank and industry rank for Echo IQ's EV-to-EBIT or its related term are showing as below:
ECHQF'
s EV-to-EBIT Range Over the Past 10 Years
Min: -103.93 Med: -8.73 Max: -0.27
Current: -67.3
During the past 13 years, the highest EV-to-EBIT of Echo IQ was -0.27. The lowest was -103.93. And the median was -8.73.
ECHQF's EV-to-EBIT is ranked worse than 100% of 468
companies
in the Healthcare Providers & Services industry
Industry Median: 15.955
vs ECHQF: -67.30
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Echo IQ's Enterprise Value for the quarter that ended in Dec. 2025 was $80.34 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Echo IQ's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $-10.72 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Echo IQ EV-to-EBIT Related Terms
Echo IQ EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Echo IQ's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Echo IQ's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Echo IQ EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Echo IQ's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Echo IQ's EV-to-EBIT falls into.
Echo IQ's current Enterprise Value is $699.73 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Echo IQ's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $-10.72 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Echo IQ (ECHQF) has a EV-to-EBIT of -65.28 as of Jul. 23, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Echo IQ and its competitors. According to the industry distribution chart, Echo IQ ranks #999999 out of 468 companies in the Healthcare Providers & Services industry.
Is Echo IQ's EV-to-EBIT too high?
Echo IQ's current EV-to-EBIT is -65.28. Based on the distribution chart, Echo IQ ranks #999999 out of 468 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Echo IQ has a GF Score™ of 13/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Echo IQ's EV-to-EBIT compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Echo IQ ranks #999999 out of 468 companies for EV-to-EBIT. This places Echo IQ in the lower half of its industry. The industry median EV-to-EBIT is 15.96. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.96, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Echo IQ and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Echo IQ's current EV-to-EBIT is -65.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Echo IQ stock overvalued right now?
Based on GuruFocus' analysis, Echo IQ (ECHQF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.02, compared to a current price of $1.25 — trading 6150% above its estimated fair value. The current EV-to-EBIT is -65.28. Echo IQ's overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Echo IQ (ECHQF), the current EV-to-EBIT is -65.28 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Echo IQ (ECHQF) Overvalued in 2026?
Based on GuruFocus' analysis, Echo IQ stock appears to be overvalued.
The current stock price of $1.25 is trading 6150% above its estimated GF Value™ of $0.02.
GuruFocus considers Echo IQ to be Significantly Overvalued.
Key valuation signals for ECHQF:
EV-to-EBIT: -65.28
GF Value™: $0.02 vs. price of $1.25 (6150% above fair value)
No single metric tells the full story. See the ECHQF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Echo IQ Ltd is an Australian medical technology company focused on improving decision-making in cardiology. Its proprietary EchoSolv platform leverages AI-driven analysis of echocardiographic data to help clinicians detect Aortic Stenosis (AS) and other conditions with greater accuracy and efficiency. The company is focused on expanding its strategic partnerships, progressing regulatory pathways, and completing successful deployments of its technology in the USA healthcare market to establish its position in AI-enabled cardiovascular care.
13GF Score
Get the complete analysis for ECHQF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ECHQF has been successfully added to your 
